意大利对欧洲乳腺癌诊断、分期与术前规划指南的改编:GRADE-ADOLOPMENT方法
意大利指南小组采用ADOLOPMENT流程改编欧洲委员会乳腺癌倡议(ECIBC)指南,基于GRADE证据到决策框架制定15条优先推荐,涵盖筛查阳性评估、可疑病灶活检方式、术前规划及分期影像检查等,所有原始ECIBC推荐均被采纳。
要点
- 筛查阳性女性评估建议用数字乳腺断层摄影替代额外乳腺摄影体位。
- 可疑钙化建议立体定向引导而非超声引导下空心针活检。
- 确诊导管原位癌不推荐额外MRI用于术前规划。
核心结论
- 意大利指南小组采用ADOLOPMENT流程改编ECIBC指南,形成15条优先推荐,所有ECIBC原始推荐均被采纳,旨在标准化欧洲乳腺癌筛查与诊断流程。
研究设计与样本
- 意大利指南小组采用ADOLOPMENT流程采纳或改编欧洲委员会乳腺癌倡议(ECIBC)指南,使用GRADE证据到决策框架,提出15条优先推荐。
诊断标准与关键数值
- 筛查阳性女性诊断建议使用数字乳腺断层摄影而非额外乳腺摄影体位。
- 可疑病灶建议使用空心针活检而非细针穿刺。
- 可疑钙化建议立体定向引导而非超声引导下空心针活检。
- 确诊导管原位癌术前规划推荐活检后放置标记夹,不推荐额外使用MRI。
- 需要时术前规划首选对比增强乳腺摄影而非MRI。
临床应用与阅片要点
- 无转移征象的I、IIa、IIb期乳腺癌不推荐其他影像检查,III期乳腺癌建议单独使用PET-CT。
- 当1%或以上肿瘤细胞显示雌激素或孕激素受体阳性时推荐辅助激素治疗,取代10%阈值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
An Italian guideline panel issued the national recommendations for breast cancer diagnosis, staging, and preoperative planning. The panel employed the ADOLOPMENT process to adopt or adapt the guidelines developed by the European Commission Initiative on Breast Cancer (ECIBC). This process utilises the Grading of Recommendations Assessment, Development and Evaluation evidence-to-decision framework. Hereby, we present 15 prioritised recommendations from the second chapter of the Italian guidelines. All of the recommendations as originally developed by the ECIBC were adopted. For the assessment of women with positive screening result, the diagnostic recommendations suggest using digital breast tomosynthesis instead of additional mammographic projections. Recommendations include using needle core biopsy (NCB) instead of fine-needle aspiration for suspicious lesions, and stereotactic-guided -rather than ultrasound-guided- NCB for suspicious calcifications. For preoperative planning, they recommend clip marking after biopsy and not using additional magnetic resonance imaging (MRI) for confirmed ductal carcinoma in situ. Contrast-enhanced mammography is preferred over MRI for presurgical planning, when needed. Other imaging tests are not recommended for stage I, IIa, and IIb BC without signs of metastasis, while positron emission tomography-computed tomography alone is suggested for stage III BC. Adjuvant hormone therapy is recommended when 1% or more tumour cells show oestrogen or progesterone receptor positivity, which replaces the 10% threshold. Adopting shared and trustworthy guidelines for BC screening across Europe will help standardise the process across settings and advance healthcare quality and equity.
引用
- Mantellini P, Guida A, Del Prete E, et al. Italian adaptation of the European guidelines for breast cancer diagnosis, staging, and preoperative planning: a GRADE-ADOLOPMENT approach. Radiol Med. 2025. PMID: 40824613. doi:10.1007/s11547-025-02065-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。